Program

September 20th (Saturday)
13-00 – 17:00

sHORT-COURSES

CoffeE-break

sHORT-COURSES

September 21st (Sunday)
8:00 – 18:00

sHORT-COURSES

CoffeE-break

sHORT-COURSES

Lunch

REgistration

September 21st (Sunday)
Geribá – 9:00 – 17:00

Young Medicinal Chemistry

Lunch

Young Medicinal Chemistry

Chair: Marilia Valli

CoffeE-break

Young Medicinal Chemistry

Chair: Marilia Valli

September 21st (Sunday)
Sala Tucuns + Tartaruga – 18:00 – 21:30

Opening Ceremony

Chairs: Dr. Floriano Paes & Dr. Lídia Lima

Opening LecturE

Chair: Dr. Rafael Guido

Replenishing the malaria drug discovery pipeline: Advances in Hit Generation for Antimalarial 
Drug Discovery

James Duffy

Medicines for Malaria Venture

Welcome reception

September 22nd (Monday)
Sala Geriba – 9:00 – 12:20

Tematic Session I:
AI in Drug discovery

Chairs: Carlos Mauricio R. Sant’Anna & Gustavo Trossini

Synergizing Computational Chemistry and AI for Early-Stage Drug Discovery

Dr. Francesco Gentile

Ottawa Institute of Systems Biology, University of Ottawa

Reaction-driven generation of bioactive compounds from ultra-large chemical spaces

Dr. Didier Rognan

University of Strasbourg

CoffeE-break

Tematic Session I:
AI in Drug discovery

Chairs: Carlos Mauricio R. Sant’Anna & Gustavo Trossini

Assault, Siege, Trojan Horses or Gentle Disarmament: Four Molecular Strategies to Fight Bacterial Infections

Mark Brönstrup

Chemische Biologie (CBIO)
HZI – Helmholtz-Zentrum für Infektionsforschung GmbH

Explainable Artificial Intelligence for the Design of Novel Anticancer RNA- and Peptide-Based Therapeutics

Dr. André Silva Pimentel

PUC-Rio

Using Generative AI for Many-Objective Small-Molecule Design

Dr. Laurent Dardenne

LNCC

September 22nd (Monday)
Sala Tucuns + Tartaruga – 9:00 – 12:20

Tematic Session II:
Early Drug Discovery

Chairs: Luzineide Tinoco & Daniela Trivella

Approaches for Natural Product Drug Discovery from compound libraries to Hit Identification

Prof. Emeritus Ronald J. Quinn

AM, FTSE – Griffith University

Putting your compounds to good use: EU-OPENSCREEN’s open compound sharing initiative

Dr. Bahne Stechmann

Deputy Director
EU-OPENSCREEN ERIC

CoffeE-break

Tematic Session II:
Early Drug Discovery

Chairs: Luzineide Tinoco & Daniela Trivella

Connecting Biology to Chemistry through High Throughput Screening

Dr Yuhong Du

Emory University, Atlanta, GA, USA

Discovery and Optimization of Small-Molecule Tools Targeting Necroptosis Cell Death

Dr. Rui Moreira

Universidade de Lisboa

The direct approach: the role of chemical proteomics in drug target deconvolution

Prof. Susan Wyllie

Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee

September 22nd (Monday)
Sala Tucuns + Tartaruga – 12:30 – 19:30

Clarivate’s Cortellis Drug Discovery Intelligence

Lunch

Lecture 1

Special Session in tribute to prof. Carlos alberto manssour Fraga

Chair: Prof. Luiz Carlos Dias

Targeting new E3 Ligases and validating them for PROTAC development

Dr. Stefan Knapp

Johann Wolfgang Goethe-University

Lecture 2

Chair: Dr. Stefan Laufer

Development and Characterization of Kinase sparing Aurora Kinase A Ligands for improved Cancer Therapy

Dr. Lars Zender

Dr. Lars Zender

Universität Tubingen

Coffee + Poster Session I

SBQ MedChem Division Meeting

ATENTION: Meeting in Geribá room

September 23rd (Tuesday)
Sala Tucuns + Tartaruga – 9:00 – 19:00

Round Table “New Challenges in the Brazilian Pharma Industry”

Mediator: Dr. Glaucius Oliva (USP)

2 blocks: 1st block 15min presentation for each debater, 2nd block: 1h mediator + audience questions

Sustainable Development, Science, Technology, and Innovation, and the Economic-Industrial Health Complex

Carlos A. Grabois Gadelha

Desenvolvimento Sustentável, CT&I e Complexo Econômico-Industrial da Saúde (CEE/ENSP–Fiocruz/MS).

Exploring R&D Synergies in Natural Products, Small Molecules and Enabling Drug Technologies

Hátylas Azevedo

Aché Laboratórios

Sustainable and Responsible Radical Innovation in Health: the CNPEM experience

Dra. Maria Augusta Arruda

Brazilian National Centre for Research in Energy and Materials (LNBIO-CNPEM)

Drug Discovery at Eurofarma Laboratórios

Luis Eduardo Reina Gamba

Head of Medicinal Chemistry – Drug Discovery, Eurofarma.

CAS BioFinder: Accelerating Drug Discovery with Intelligence and Biological Connections

Dr. Marina Melchiors, Ph.D.

Customer Success Specialist, CAS

Lunch

Free time

Coffee + Poster Session II

SOCIAL EVENT: Pool Party Barbecue

Limited to those who purchased the invitation

September 24th (Wedsneday)
Sala Geriba – 9:00 – 14:00

Tematic Session III:
Lead-Optimization & DMPK

Chairs: Sabrina B. Ferreira & Rafaela Ferreira

Optimization of Neurolysin Activators as Potential Therapeutic Options in Ischemic Stroke

Dr. Paul C. Trippier

University of Nebraska

My 4 decades journey in Pharma : riding the wave of change

Dr. Luc Van Hijfte

Novalix, Senior advisor Drug Discovery

CoffeE-break

Tematic Session III:
Lead-Optimization & DMPK

Chairs: Sabrina B. Ferreira & Rafaela Ferreira

In Vitro and In Vivo Development of β-Lactam-Metallo-β-Lactamase Inhibitors: Targeting Carbapenem-Resistant Enterobacterales

Dr. Tricia Naicker

University of KwaZulu-Natal

Probing the Protein Kinases′ Cysteinome by Covalent Fragments

Dr. Matthias Gehringer

University of University of Tübingen

Photo Copyright: Universitätsklinikum
Tübingen / Beate Armbruster”

From Concept to Practice: The Contribution of PBPK Modeling in Early Drug Development

Dr. Andrea Diniz

Universidade Estadual de Maringá

Lunch

September 24th (Wedsneday)
Sala Tucuns + Tartaruga – 9:00 – 14:00

Tematic Session IV:
Frontiers in drug discovery

Chair: Arthur Kummerle & João Paulo S. Fernandes

Deconvoluting RNA Binding proteins as drug targets, by chromatography-based chemical fragment screening

Dr. Katlin Brauer Massirer

Researcher at the Center for Molecular Biology and Genetics at Unicamp

3′-Deoxy-3′,4′-didehydro-nucleosides and ProTides as Potent Antiviral Agents

Dr. Daniel A. Harki

University of Minnesota

CoffeE-break

Tematic Session IV:
Frontiers in drug discovery

Chair: Arthur Kummerle & João Paulo S. Fernandes

Using DNA-Encoded Libraries for Drug Discovery in Academia

Dr. Damian W. Young

Baylor College of Medicine, USA

Microfluidic “organ-on-a-chip” tissue culture model systems
for drug testing and toxicity studies

Dr. Stefan Wölfl

University of Heidelberg

Pushing Ethical and Scientific Frontiers: Tissue Engineering and Organs-on-a-Chip for Therapy Development

Ana Carolina Migliorini Figueira

Lider Researcher, Advanced Cluster in Tissue ENginerring – NuTET /
Advanced Cluster in Helth Technologies – NATS / Laboratorio Nacional de Biociências -LNBio – CNPEM

ACS on Campus

September 24th (Wedsneday)
Sala Tucuns + Tartaruga – 14:00 – 16:30

Lecture 3

Chair: Vitor Francisco Ferreira

Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis

Ashvani Singh

Senior Principal Research Scientist, Abbvie, USA

Lecture 4

Chair: Maria Cristina Nonato

Discovery of NTX-801, a potent Cbl-b inhibitor with antitumor activity in syngeneic models

Dr. Silvana Leit

Executive Director, Nimbus Therapeutics. US

CoffeE-break

September 24th (Wedsneday)
Sala Geriba – 16:30 – 18:30

Coordinated session 1

Chairs: Marcela Moraes & Jean L. dos Santos

September 24th (Wedsneday)
Sala Tucuns + Tartaruga – 16:30 – 18:30

Coordinated session 2

Chairs: Nailton Nascimento Jr & Marjorie Bruder

September 24th (Wedsneday)
18:30 – 21:00

Closing Ceremony

Confraternization